Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos)
A Tenenhouse et al., 2001
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 11(10), 897-904
The Canadian Multicentre Osteoporosis Study (CaMos) is a prospective cohort study which will measure the incidence and prevalence of osteoporosis and fractures, and the effect of putative risk factors, in a random sample of 10,061 women and men aged > or = 25 years recruited in approximately equal numbers in nine centers across Canada. In this paper we report the results of studies to establish peak bone mass (PBM) which would be appropriate reference data for use in Canada. These reference data are used to estimate the prevalence of osteoporosis and osteopenia in Canadian women and men aged > or = 50 years. Participants were recruited via randomly selected household telephone listings. Bone mineral density (BMD) of the lumbar spine and femoral neck were measured by dual-energy X-ray absorptiometry using Hologic QDR 1000 or 2000 or Lunar DPX densitometers. BMD results for lumbar spine and femoral neck were converted to a Hologic base. BMD of the lumbar spine in 578 women and 467 men was constant to age 39 years giving a PBM of 1.042 +/- 0.121 g/cm2 for women and 1.058 +/- 0.127 g/cm2 for men. BMD at the femoral neck declined from age 29 years. The mean femoral neck BMD between 25 and 29 years was taken as PBM and was found to be 0.857 +/- 0.125 g/cm2 for women and 0.910 +/- 0.125 g/cm2 for men. Prevalence of osteoporosis, as defined by WHO criteria, in Canadian women aged > or = 50 years was 12.1% at the lumbar spine and 7.9% at the femoral neck with a combined prevalence of 15.8%. In men it was 2.9% at the lumbar spine and 4.8% at the femoral neck with a combined prevalence of 6.6%.
Canadian Multicentre Osteoporosis Study CaMos bone density, DXA reference standard peak bone mass Canadian population, osteoporosis prevalence Canadian women men over 50, Prior JC bone mineral density population study, Tenenhouse CaMos osteoporosis prevalence Canada, femoral neck lumbar spine BMD age-related decline, WHO criteria osteoporosis prevalence dual energy X-ray absorptiometry, peak bone mass reference data population-specific DXA, osteopenia prevalence bone density Canadian cohort, Hologic Lunar densitometer BMD conversion prospective cohort
PMID 11199195 11199195 DOI 10.1007/s001980070050 10.1007/s001980070050
Cite this article
Tenenhouse, A., Joseph, L., Kreiger, N., Poliquin, S., Murray, T. M., Blondeau, L., Berger, C., Hanley, D. A., Prior, J. C., & CaMos Research Group.Canadian Multicentre Osteoporosis Study (2000). Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). *Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA*, *11*(10), 897-904. https://doi.org/10.1007/s001980070050
Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 2000;11(10):897-904. doi:10.1007/s001980070050
Tenenhouse, A., et al. "Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos)." *Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA*, vol. 11, no. 10, 2000, pp. 897-904.
Anna M Sawka et al., 2006Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
Routine bone mineral densitometry (BMD) screening has been recommended for women aged >or=65 yr (Osteoporosis Canada [OC], International Society for Clinical Densitometry [ISCD], Canadian and United S...
Bone Health > Screening > Population-Based BMD TestingBone Health > Epidemiology > Osteoporosis PrevalenceResearch Methodology > Study Design > Population-Based Screening
Yang YB et al., 2020Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Sclerostin, a natural hormone made in bone, suppresses bone formation. Sclerostin is also decreased by estrogen. Progesterone, estrogen's menstrual partner, stimulates bone formation. It is unclear wh...
Perimenopause/Menopause > Hormone Therapy > ProgesteroneBone Health > Bone Biomarkers > SclerostinResearch Methodology > Randomized Controlled Trial > Post Hoc Analysis
E Kingwell et al., 2009Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
This population-based study of mid-aged Canadians assessed awareness of diagnosis by bone mineral density (BMD) following dual-energy X-ray absorptiometry (DXA) testing and compared the effects of fee...
Bone Health > Screening > BMD Testing CommunicationBone Health > Osteoporosis > Patient Awareness and RecallResearch Methodology > Prospective Cohort > Population-Based Studies
A Papaioannou et al., 2008Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Using prospective data from the Canadian Multicentre Osteoporosis Study (CaMos), we compared health utilities index (HUI) scores after 5 years of follow-up among participants (50 years and older) with...